Trials / Conditions / Embolism and Thrombosis

Embolism and Thrombosis

24 registered clinical trials studyying Embolism and Thrombosis — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The ReCAna for Lower ExtremIty Venous OBstructions and In-StEnt Restenosis Registry NCT07529756	Intervene, Inc.	—
Not Yet Recruiting	Prolonged Anticoagulation Therapy on the Prognosis of Patients With Left Ventricular Thrombosis NCT06209892	Chinese Academy of Medical Sciences, Fuwai Hospital	N/A
Active Not Recruiting	Aventus Thrombectomy System Pulmonary Embolism Clinical Study NCT05907564	Inquis Medical, Inc.	N/A
Recruiting	Observational Dutch Young Symptomatic StrokE studY - nEXT NCT05853796	Radboud University Medical Center	—
Recruiting	Collection of Blood Samples for New Diagnostic Devices 2 NCT05568966	LumiraDx UK Limited	N/A
Completed	A Study to Compare Pharmacokinetic Parameters and Safety Profiles Between AD-109 and AD-1091 NCT05128591	Addpharma Inc.	Phase 1
Recruiting	Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism NCT04304651	University Hospital, Brest	N/A
Completed	Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients NCT04439383	Insel Gruppe AG, University Hospital Bern	—
Recruiting	Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism NCT04263038	Drahomir Aujesky	Phase 4
Unknown	COVID-19, bLOod Coagulation and Thrombosis NCT04388657	Ramsay Générale de Santé	—
Unknown	Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests NCT04375982	LumiraDx UK Limited	N/A
Completed	Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 NCT04368377	University of Milan	Phase 2
Completed	Safety and Efficiency of the YEARS Algorithm Versus Computed Tomography Pulmonary Angiography Alone for Suspec NCT04657120	Leiden University Medical Center	N/A
Terminated	Medical Assistance for the Procreation and Risk of Thrombosis. NCT02610608	University Hospital, Brest	—
Completed	Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagula NCT02720328	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	Phase 4
Completed	Comparison of Accidents and Their Circumstances With Oral Anticoagulants NCT02376777	CNGE IRMG Association	—
Completed	Platelet Activity in Vascular Surgery for Thrombosis and Bleeding NCT01897103	NYU Langone Health	—
Completed	Registry of AngioJet Use in the Peripheral Vascular System NCT01086215	Boston Scientific Corporation	—
Completed	A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty NCT01203098	Daiichi Sankyo Co., Ltd.	Phase 2
Completed	The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice NCT00830570	Medco Health Solutions, Inc.	—
Completed	Traumatic Intracranial Hemorrhage in Users of Oral Antithrombotic Drugs NCT02996851	St. Olavs Hospital	—
Completed	Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial) NCT00119457	vTv Therapeutics	Phase 2
Completed	Epidemiology of Thromboembolism Disease: A Cohort Study NCT00670540	University Hospital, Grenoble	—
Completed	The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Da NCT00216866	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	Phase 2